Many studies of tauopathy use transgenic mice that overexpress the P301S mutant form of tau. Neuronal damage in these mice is associated with astrogliosis and induction of glial fibrillary acidic protein (GFAP) expression. GFAP-luc transgenic mice express firefly luciferase under the GFAP promoter, allowing bioluminescence to be measured non-invasively as a surrogate biomarker for astrogliosis. […]
Published on September 12, 2019
Accumulating evidence suggests that active maintenance of optimal levels of the essential pyridine nucleotide, nicotinamide adenine dinucleotide (NAD+) is beneficial in conditions of either increased NAD+ turnover or inadequate synthesis, including Alzheimer’s disease and other neurodegenerative disorders and the aging process. While studies have documented the efficacy of some NAD+ precursors such as nicotinamide riboside […]
Published on September 12, 2019
In addition to conscious goals and stimulus salience, an observer’s prior experience also influences selective attention. Early studies demonstrated experience-driven effects on attention mainly in the visual modality, but increasing evidence shows that experience drives auditory selection as well. We review evidence for a multiple-levels framework of auditory attention, in which experience-driven attention relies on […]
Published on September 12, 2019